Cargando…
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19
BACKGROUND: Lungs from patients with coronavirus disease 2019 (COVID-19) have shown typical signs of acute respiratory distress syndrome (ARDS), formation of hyaline membrane mainly composed of fibrin and ‘ground-glass’ opacity. Previously, we showed plasminogen itself is a key regulator in fibrin d...
Autores principales: | Wu, Y, Wang, T, Guo, C, Zhang, D, Ge, X, Huang, Z, Zhou, X, Li, Y, Peng, Q, Li, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184376/ https://www.ncbi.nlm.nih.gov/pubmed/32275753 http://dx.doi.org/10.1093/qjmed/hcaa121 |
Ejemplares similares
-
Pathophysiology of Hypoxemia in COVID-19 Lung Disease
por: Swenson, Kai E., et al.
Publicado: (2023) -
Modulation of Hb-O(2) affinity to improve hypoxemia in COVID-19 patients
por: Woyke, Simon, et al.
Publicado: (2021) -
Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
por: Trinchieri, Vito, et al.
Publicado: (2022) -
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
por: Archer, Stephen L., et al.
Publicado: (2022) -
COVID-19–Positive Patient and Hypoxemia: Are Lungs Always to Be Blamed?
por: Kass, Malek, et al.
Publicado: (2021)